| scholarly article | Q13442814 |
| P50 | author | Germano Di Sciascio | Q59188165 |
| Achille Gaspardone | Q90007264 | ||
| Giuseppe Patti | Q37370554 | ||
| P2093 | author name string | Vincenzo Pasceri | |
| Antonio Montinaro | |||
| Giuseppe Colonna | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| statin therapy | Q62562875 | ||
| myocardial damage | Q21112456 | ||
| angioplasty | Q539795 | ||
| P304 | page(s) | 558-565 | |
| P577 | publication date | 2009-07-02 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial | |
| P478 | volume | 54 |
| Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
| Q48123127 | 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document |
| Q53175089 | A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI). |
| Q54304368 | A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. |
| Q38097397 | A review of statin use in patients with acute coronary syndrome in Western and Japanese populations |
| Q34116819 | Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx |
| Q35919438 | Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention |
| Q38824464 | Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions |
| Q28266939 | Biosynthesis of isoprenoids via the non-mevalonate pathway |
| Q26866366 | Cardioprotection during cardiac surgery |
| Q38451245 | Cellular and molecular mechanisms of statins: an update on pleiotropic effects |
| Q42329767 | Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI. |
| Q39549621 | Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction |
| Q47199202 | Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial). |
| Q53414872 | Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era. |
| Q41082977 | Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to p |
| Q38099287 | Defining the role of high-dose statins in PCI. |
| Q38194363 | Dipeptidyl peptidase IV inhibitors and ischemic myocardial injury |
| Q37941867 | Do statins have a role in reduction/prevention of post-PCI restenosis? |
| Q47638413 | Does the use of statins improve outcomes in coronary artery bypass graft surgery? |
| Q34354040 | Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. |
| Q90329680 | Early treatment with high-potency statins in patients with acute coronary syndrome-an example of personalized medicine |
| Q50961322 | Effect of Atorvastatin Therapy on the Level of CD34+CD133+CD309+ Endothelial Progenitor Cells in Patients with Coronary Heart Disease |
| Q50957420 | Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial |
| Q38340107 | Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction |
| Q61445734 | Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies |
| Q38600680 | Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis |
| Q88017326 | Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial |
| Q43812550 | Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes |
| Q34338642 | Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes |
| Q97533779 | Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention |
| Q38437548 | Effect of previous statin therapy in patients with acute coronary syndrome and percutaneous coronary intervention |
| Q36493187 | Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI). |
| Q37976137 | Effect of statins therapy prior to percutaneous coronary intervention |
| Q37434520 | Effects of atorvastatin loading prior to primary percutaneous coronary intervention on endothelial function and inflammatory factors in patients with ST-segment elevation myocardial infarction |
| Q47095431 | Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Ac |
| Q60912594 | Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial |
| Q47286408 | Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry |
| Q52149033 | Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention. |
| Q64073505 | Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial |
| Q39680106 | Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention |
| Q51740593 | Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis. |
| Q26797400 | Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials |
| Q39121106 | Endothelial progenitor cells: Exploring the pleiotropic effects of statins |
| Q54568467 | Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. |
| Q37731694 | High dose statin prophylaxis in cardiopulmonary bypass related surgery: clinical utility. |
| Q49577001 | High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery |
| Q36832295 | High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial |
| Q42378434 | High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention |
| Q44356691 | High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period |
| Q47109768 | High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction |
| Q34634358 | High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials |
| Q42860809 | High-dose statin therapy for high-risk patients |
| Q54657839 | Inhibition of p38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans |
| Q43097998 | Intensive statin therapy: a favorable adjunct to the improvement of small-diameter vascular grafts |
| Q37941943 | Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? |
| Q39524792 | LDL Lowering After Acute Coronary Syndrome: Is Lower Better? |
| Q37606038 | Lipoproteins, platelets and atherothrombosis |
| Q33732277 | Naproxen and Diclofenac Attenuate Atorvastatin-induced Preconditioning of the Myocardium |
| Q82598497 | Outcomes of high dose statin loading therapy |
| Q34147112 | Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. |
| Q37782048 | Periprocedural Myocardial Infarction: Review and Classification |
| Q38830803 | Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study. |
| Q37851481 | Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering |
| Q34894749 | Pleiotropic effects of the HMG-CoA reductase inhibitors |
| Q38635408 | Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI. |
| Q33808599 | Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries |
| Q85195746 | Pre-procedural use of statins for all patients undergoing percutanous coronary intervention |
| Q48786933 | Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage |
| Q24187896 | Preoperative statin therapy for patients undergoing cardiac surgery |
| Q24200475 | Preoperative statin therapy for patients undergoing cardiac surgery |
| Q24236372 | Preoperative statin therapy for patients undergoing cardiac surgery |
| Q26472003 | Preoperative statin therapy for patients undergoing cardiac surgery |
| Q42359961 | Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial |
| Q54203490 | Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events? |
| Q40338622 | Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition |
| Q36837567 | Role of statins in coronary artery disease |
| Q37629827 | Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. |
| Q46252433 | Rosuvastatin reloading before cardiac surgery with cardiopulmonary bypass. |
| Q91922910 | Should We Tip Our CAPs to Statins? |
| Q36992366 | Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention |
| Q44681767 | Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial |
| Q37798804 | Statin loading before percutaneous coronary intervention: proposed mechanisms and applications |
| Q92587930 | Statin reload before off-pump coronary artery bypass graft: Effect on biomarker release kinetics |
| Q41374557 | Statin treatment before percutaneous cononary intervention. |
| Q38573070 | Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q42348666 | Statins before stents: Does an ounce of prevention improve outcomes? |
| Q34729472 | Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins. |
| Q37786646 | Stents and statins: history, clinical outcomes and mechanisms |
| Q38010782 | Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy |
| Q33696402 | The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...] |
| Q36342262 | The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy. |
| Q35059481 | The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome |
| Q37830053 | The optimal pharmacological formula for percutaneous coronary intervention |
| Q37350270 | The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy |
| Q92666334 | Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention |
| Q91837095 | Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial |
| Q57658256 | Traitement hypolipidémiant en prévention secondaire |
| Q33887918 | Update on lipids and C-reactive protein in acute and chronic coronary heart disease |
| Q34408660 | Update on the efficacy of statin treatment in acute coronary syndromes |
| Q87367503 | [Cardioprotection in cardiac surgical patients : Everything good comes from the heart] |
| Q53067650 | [New aspects of perioperative statin therapy]. |
Search more.